Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.

× No keyword cloud information.

16 in total

1. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.

Authors: P Zhu; L Lu; Y Xu; C Greyson; G G Schwartz
Journal: Am J Physiol Heart Circ Physiol Date: 2000-02 Impact factor: 4.733

2. Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

Authors: E M Runnman; S T Lamp; J N Weiss
Journal: J Clin Invest Date: 1990-10 Impact factor: 14.808

3. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.

Authors: Harry P Selker; Joni R Beshansky; John L Griffith; Ralph B D'Agostino; Joseph M Massaro; James E Udelson; Eric J Rashba; Robin Ruthazer; Patricia R Sheehan; Patrice Desvigne-Nickens; Yves D Rosenberg; James M Atkins; Assaad J Sayah; Tom P Aufderheide; Charles E Rackley; Lionel H Opie; Costas T Lambrew; Leonard A Cobb; Bruce A Macleod; Joanne S Ingwall; Robert J Zalenski; Carl S Apstein
Journal: Am Heart J Date: 2012-03 Impact factor: 4.749

Review 4. Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting.

Authors: Stacey A Seggelke; Mark C Lindsay; Ingrid Hazlett; Rebecca Sanagorski; Robert H Eckel; Cecilia C Low Wang
Journal: Curr Diab Rep Date: 2017-08 Impact factor: 4.810

5. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors: Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal: JAMA Date: 2012-03-27 Impact factor: 56.272

6. Metabolic fate of extracted glucose in normal human myocardium.

Authors: J A Wisneski; E W Gertz; R A Neese; L D Gruenke; D L Morris; J C Craig
Journal: J Clin Invest Date: 1985-11 Impact factor: 14.808

Review 7. Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Authors: Abhinav Goyal; Kara Nerenberg; Hertzel C Gerstein; Guillermo Umpierrez; Peter W F Wilson
Journal: Diab Vasc Dis Res Date: 2008-11 Impact factor: 3.291

Review 8. The heart in diabetes.

Authors: D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal: West J Med Date: 1984-04

9. High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study.

Authors: Yanhui Li; Lin Zhang; Lei Zhang; Haiyong Zhang; Nianzhong Zhang; Zhongsu Yang; Mingming Gao; Xinchun Yang; Liang Cui
Journal: J Cardiovasc Dis Res Date: 2010-07

Review 10. Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors: P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal: J Endocrinol Invest Date: 2004-05 Impact factor: 4.256